Anti-CNGA4/ CNCA2/ CNG-4 monoclonal antibody

Anti-CNGA4/ CNCA2/ CNG-4 antibody for FACS & in-vivo assay

Target products collectionGo to CNGA4/CNGA4 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-MP0309-Ab-1/ GM-Tg-hg-MP0309-Ab-2Anti-Human CNGA4 monoclonal antibodyHuman
GM-Tg-rg-MP0309-Ab-1/ GM-Tg-rg-MP0309-Ab-2Anti-Rat CNGA4 monoclonal antibodyRat
GM-Tg-mg-MP0309-Ab-1/ GM-Tg-mg-MP0309-Ab-2Anti-Mouse CNGA4 monoclonal antibodyMouse
GM-Tg-cynog-MP0309-Ab-1/ GM-Tg-cynog-MP0309-Ab-2Anti-Cynomolgus/ Rhesus macaque CNGA4 monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-MP0309-Ab-1/ GM-Tg-felg-MP0309-Ab-2Anti-Feline CNGA4 monoclonal antibodyFeline
GM-Tg-cang-MP0309-Ab-1/ GM-Tg-cang-MP0309-Ab-2Anti-Canine CNGA4 monoclonal antibodyCanine
GM-Tg-bovg-MP0309-Ab-1/ GM-Tg-bovg-MP0309-Ab-2Anti-Bovine CNGA4 monoclonal antibodyBovine
GM-Tg-equg-MP0309-Ab-1/ GM-Tg-equg-MP0309-Ab-2Anti-Equine CNGA4 monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-MP0309-Ab-1/ GM-Tg-hg-MP0309-Ab-2; GM-Tg-rg-MP0309-Ab-1/ GM-Tg-rg-MP0309-Ab-2;
GM-Tg-mg-MP0309-Ab-1/ GM-Tg-mg-MP0309-Ab-2; GM-Tg-cynog-MP0309-Ab-1/ GM-Tg-cynog-MP0309-Ab-2;
GM-Tg-felg-MP0309-Ab-1/ GM-Tg-felg-MP0309-Ab-2; GM-Tg-cang-MP0309-Ab-1/ GM-Tg-cang-MP0309-Ab-2;
GM-Tg-bovg-MP0309-Ab-1/ GM-Tg-bovg-MP0309-Ab-2; GM-Tg-equg-MP0309-Ab-1/ GM-Tg-equg-MP0309-Ab-2
Products NameAnti-CNGA4 monoclonal antibody
Formatmab
Target NameCNGA4
Protein Sub-locationTransmembrane Protein
Category of antibodyFACS/Biofunctional Antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by using flow cytometry with antigen overexpressed cell line. The biofunction of antibodies are validated in cell-based assay (IC50 or EC50 TBD).
TagFc
Products descriptionPre-made anti-CNGA4 benchmark inhibitory monoclonal antibody(mab) (blocking antibody inhibitor) is expressed by mammalian cell line as a benchmark antibody for cell culture, FACS,ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenProducts DevelopingMulti-species CNGA4/ CNCA2/ CNG-4 VLP (virus-like particle) (Products Developing)
    ORF Viral VectorvGMLP004446human CNGA4 Lentivirus particle
    ORF Viral VectorpGMLP004446human CNGA4 Lentivirus plasmid
    ORF Viral VectorpGMLPm003392mouse Cnga4 Lentivirus plasmid
    ORF Viral VectorvGMLPm003392mouse Cnga4 Lentivirus particle


    Target information

    Target IDGM-MP0309
    Target NameCNGA4
    Gene ID1262,233649,85258,713010,476830,101089799,516000,100055033
    Gene Symbol and SynonymsCgn2,CNCA2,CNG-4,CNG4,CNG5,CNGA4,CNGB2,OCNC2,OCNCb,OCNCBETA,rOCNC2
    Uniprot AccessionQ8IV77,Q64359
    Uniprot Entry NameCNGA4_HUMAN,CNGA4_RAT
    Protein Sub-locationTransmembrane Protein
    Category
    DiseaseN/A
    Gene EnsemblENSG00000132259
    Target ClassificationN/A

    The target: CNGA4, gene name: CNGA4, also named as CNCA2, CNG-4, CNG4, CNG5, CNGB2, OCNC2, OCNCBETA, OCNCb. CNGA4 is a modulatory subunit of vertebrate cyclic nucleotide-gated membrane channels that transduce odorant signals (Munger et al., 2001 [PubMed 11739959]).[supplied by OMIM, Mar 2008].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.